Detalhe da pesquisa
1.
Kidney-Specific CAP1/Prss8-Deficient Mice Maintain ENaC-Mediated Sodium Balance through an Aldosterone Independent Pathway.
Int J Mol Sci
; 23(12)2022 Jun 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35743186
2.
SPINT2 (HAI-2) missense variants identified in congenital sodium diarrhea/tufting enteropathy affect the ability of HAI-2 to inhibit prostasin but not matriptase.
Hum Mol Genet
; 28(5): 828-841, 2019 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30445423
3.
Insights into the regulation of the matriptase-prostasin proteolytic system.
Biochem J
; 477(22): 4349-4365, 2020 11 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33094801
4.
Inhibition of an active zymogen protease: the zymogen form of matriptase is regulated by HAI-1 and HAI-2.
Biochem J
; 477(9): 1779-1794, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32338287
5.
Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors.
J Biol Chem
; 294(1): 314-326, 2019 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-30409910
6.
HAI-2 stabilizes, inhibits and regulates SEA-cleavage-dependent secretory transport of matriptase.
Traffic
; 18(6): 378-391, 2017 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28371047
7.
The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
J Biol Chem
; 289(32): 22319-32, 2014 Aug 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-24962579
8.
Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation.
PLoS Genet
; 8(8): e1002937, 2012.
Artigo
em Inglês
| MEDLINE | ID: mdl-22952456
9.
A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation.
J Biol Chem
; 288(26): 19028-39, 2013 Jun 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-23673661
10.
Hepatocyte growth factor activator inhibitor-2 prevents shedding of matriptase.
Exp Cell Res
; 319(6): 918-29, 2013 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23333561
11.
Transport via the transcytotic pathway makes prostasin available as a substrate for matriptase.
J Biol Chem
; 286(7): 5793-802, 2011 Feb 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-21148558
12.
Understanding HAIs: Ally proteins in the fight against cancer.
FEBS J
; 289(12): 3416-3418, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35220685
13.
Expression profile of the N-myc Downstream Regulated Gene 2 (NDRG2) in human cancers with focus on breast cancer.
BMC Cancer
; 11: 14, 2011 Jan 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-21226903
14.
The level of claudin-7 is reduced as an early event in colorectal carcinogenesis.
BMC Cancer
; 11: 65, 2011 Feb 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-21310043
15.
Collagen mRNA levels changes during colorectal cancer carcinogenesis.
BMC Cancer
; 9: 136, 2009 May 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-19422682
16.
Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.
BMC Cancer
; 9: 201, 2009 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-19555470
17.
CD13 is a novel mediator of monocytic/endothelial cell adhesion.
J Leukoc Biol
; 84(2): 448-59, 2008 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-18495788
18.
Hepatocyte growth factor activator inhibitor-1 has a complex subcellular itinerary.
Biochem J
; 413(2): 251-9, 2008 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-18402552
19.
Expression of NDRG2 is down-regulated in high-risk adenomas and colorectal carcinoma.
BMC Cancer
; 7: 192, 2007 Oct 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-17935612
20.
The ratio of Matriptase/HAI-1 mRNA is higher in colorectal cancer adenomas and carcinomas than corresponding tissue from control individuals.
BMC Cancer
; 6: 176, 2006 Jul 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-16820046